you would think with covid, RSH would have much higher sales in Australia given it helps detect wheeze??. I think Cipla may not have been the right partner. Also, like the Australian launch, the attempted acquisition was poorly executed and a big flop. let's see if the "superstars" can handle US and UK
chart, page-1765
-
- There are more pages in this discussion • 350 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
